Skip to main content
. 2023 May 10;9(5):551. doi: 10.3390/jof9050551

Table 4.

Summary of the effects of H. erinaceus treatment on the GM in different models.

Model/Condition/Disease Treatment (Doses and Duration) Increased Bacteria Decreased Bacteria Other Effects Reference
In vitro (after simulated gastrointestinal digestion and 24-h-fermentation) on fermentation broth of human feces HEPs 1 (HEP-30, HEP-50, and HEP-70) SCFA 2-producing bacteria: Lactobacillus, Faecalibacterium, Bifidobacterium, Blautia, Butyricicoccus Pathogenic bacteria: Klebsiella, Escherichia-Shigella, Enterobacter - [110]
In vitro (static batch culture 24 h fermentations and fecal inocula from elderly donors) HEBS 3 and HEOLRP 4 - - Increasing propionate and butyrate levels. [113]
Healthy adults (30.0 ± 4.9 years old) 1 g of H. erinaceus powder three times a day (7 days of washout) SCFA-producing bacteria: Eubacterium rectale, Faecalibacterium prausnitzii, Kineothrix alysoides, Gemmiger formicilis, Fusicatenibacter saccharivorans Pathobionts: Bacteroides caccae, Streptococcus thermophilus, Romboutsia timonensis Increasing in GM 5 alpha diversity. GM changes related to blood ALP 6, LDL 7, UA 8, and CREA 9. [112]
Aged dogs H. erinaceus 0.8 g per bw 10 with daily diets for 16 weeks Bacteroidetes (order Bacteroidales) Firmicutes: Streptococcus, Tyzzerella, Campylobacteraceae (genus Campylobacter) - [114]
Middle (8-week-old) and old (6-month-old)-aged mice HEPs from the H. erinaceus sporophore 0.5 or 1 g/bw/day by gavage for 28 days Lachnospiraceae, Akkermansiaceae Rikenellaceae, Bacteroidaceae Anti-inflammatory activity and immunomodulatory activity. [115]
Acetic-acid-induced UC 11 adult rats EP-1 12 0.6 and 1.2 g/kg by gavage for 11 days SCFA producers - Antioxidant, anti-inflammatory, and immunoregulatory activities. Restoring a normal GM. [116]
DSS 13-induced UC C57BL/6 adult male mice HEP10 14 50, 100, or 200 mg/kg by gavage for 7 days Akkermansia muciniphila. Proteobacteria Restoring GM-alpha and -beta diversities. Anti-inflammatory activity in colons. [117]
IBD 15 adult rats and mice HE/HEP3 100 mg/(kg * day) by gavage for 14 days Anti-inflammatory bacteria, Corynebacterium, Bacteroides, Enterobacter, Acinetobacter, Desulfovibrio, Lactobacillus Pro-inflammatory bacteria Anti-inflammatory activity. Improving the GM composition. [118,119]
CTX 16-immunodeficient adult mice HEP and FHEP 300 mg/kg/day by gavage for 21 days Bacteriodetes, Firmicutes Klebsiella and Shigella Anti-inflammatory activity. Improving TJ 17 and MUC 18 expression. [111]
CTX-immunodeficient adult mice HEPs 75, 150, and 300 mg/kg by gavage for 4 weeks SCFA-producing bacteria, Alistipse, Muribaculaceae, Lachnospiraceae_NK4A136_group, Lachnospiracea, Ruminococcaceae, Ruminococcaceae_UCG-014 Lactobacillus, Bacteroides, Alloprevotella Improving the body weight and immune organ index. Increasing OTUs and adjusting GM-alpha and -beta diversities. [121]
Xenograft adult male Balb/C mice, implanting with 100,000 CT-26 wt cancer cells HEP 100 mg/kg/day per os for 21 days Probiotic bacteria: Bifidobacterium, Gemellales, Blautia, Sutterella, Anaerostipes, Roseburia, Lachnobacterium, Lactobacillus, and Desulfovibrio Parabacteroides, Christensenellaceae, Anoxybacillus, Staphylococcus, Aggregatibacter, Comamonadaceae, Desulfovibrionaceae, Sporosarcina, Planococcaceae, Aerococcaceae, Flavobacteriaceae, and Bilophila Reducing the 5-Fu-induced GM dysbiosis, suppressing tumor growth, and inhibiting inflammatory markers. [120]

Abbreviations: 1 H. erinaceus polysaccharides (HEPs), 2 shorty-chain fatty acid (SCFA), 3 H. erinaceus LGAM 4514 in 100% beech sawdust (HEBS), 4 H. erinaceus LGAM 4514 in olive pruning residues (HEOLRP), 5 gut microbiota (GM), 6 alkaline phosphatase (ALP), 7 low-density lipoprotein (LDL), 8 uric acid (UA), 9 creatinine (CREA), 10 body weight (Bw), 11 ulcerative colitis (UC), 12 purified unique polysaccharide isolated from H. erinaceus mycelium (EP-1), 13 dextran sulfate sodium (DSS), 14 low-weight polysaccharide from H. erinaceus with Mw: 9.9 kDa (HEP10), 15 intestinal bowel disease (IBD), 16 cyclophosphamide (CTX), 17 tight junctions (TJ), 18 mucin (MUC).